Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Chemotherapy and Pharmacology
Published in: Cancer Chemotherapy and Pharmacology 6/1997

01-09-1997 | ORIGINAL ARTICLE

Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil

Authors: Mohan Chelladurai, Catherine A. Lobocki, Mtanius Sultani, Yoseff Hanna, Anibal Drelichman, David R. Pieper, Patrick W. McLaughlin

Published in: Cancer Chemotherapy and Pharmacology | Issue 6/1997

Login to get access
Metadata
Title
Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil
Authors
Mohan Chelladurai
Catherine A. Lobocki
Mtanius Sultani
Yoseff Hanna
Anibal Drelichman
David R. Pieper
Patrick W. McLaughlin
Publication date
01-09-1997
Publisher
Springer-Verlag
Published in
Cancer Chemotherapy and Pharmacology / Issue 6/1997
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s002800050688

Other articles of this Issue 6/1997

Cancer Chemotherapy and Pharmacology 6/1997 Go to the issue

ORIGINAL ARTICLE

The inactivation of doxorubicin by long ultraviolet light

ORIGINAL ARTICLE

GS-164, a small synthetic compound, stimulates tubulin polymerization by a similar mechanism to that of Taxol

ORIGINAL ARTICLE

Methyl-β-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: effect on the cytotoxic activity and intracellular accumulation of doxorubicin

ORIGINAL ARTICLE

The effects of anesthesia on the biodistribution of drugs in rats: a carboplatin study

ORIGINAL ARTICLE

Pharmacokinetics of Adriamycin and cisplatin for anhepatic chemotherapy during liver transplantation

SHORT COMMUNICATION

Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits